Mirtazapine Tablet, Film Coated
Product Images NDC 0615-8663

3 FDA label images from Ncs Healthcare Of Ky, Llc Dba Vangard Labs · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 0615-8663). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structure (Mirtazapine 8663 1)

Structure (Mirtazapine 8663 1)
Chemical structure diagram of Mirtazapine, the active ingredient shown in the image. The structure includes fused ring systems containing nitrogen atoms and a methyl group attached to a nitrogen atom in the molecular framework.*
FDA Label Image

Table (Mirtazapine 8663 2)

Table (Mirtazapine 8663 2)
Text panel listing behavioral and emotional warning signs including suicidal thoughts, aggressive behavior, new or worsening depression or anxiety, panic attacks, irritability, mania, restlessness, trouble sleeping, and other unusual mood or behavior changes.*
FDA Label Image

Principal Display Panel (Mirtazapine 8663 3)

Principal Display Panel (Mirtazapine 8663 3)
Mirtazapine Tablets, USP 7.5 mg, film-coated oral tablets. The label shows packaging by Vanguard Labs, Glasgow, KY, with lot number 8663 and quantity of 30 tablets. Instructions indicate storage between 20°C to 25°C, with exceptions, and the same dosage for institutional use only. The label also includes multiple barcodes and batch information for hospital or institutional packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.